郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Potency, efficacy, and selectivity of GR64349 at human recombinant neurokinin NK2 and NK1 receptors.

期刊：Neuroscience letters发表年份：2019作者：Elisabetta Perdona; Palmina Cavallini; Anna Sava; Cristiana Griffante; Daniel J Ricca; Karl B Thor; Nadia M J Rupniak; Mauro Corsi
阅读更多 →

药效评价Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain.

期刊：Journal of medicinal chemistry发表年份：2019作者：Matteo Falsini; Daniela Catarzi; Flavia Varano; Costanza Ceni; Diego Dal Ben; Gabriella Marucci; Michela Buccioni; Rosaria Volpini; Lorenzo Di Cesare Mannelli; Elena Lucarini; Carla Ghelardini; Gianluca Bartolucci; Marta Menicatti; Vittoria Colotta
阅读更多 →

药效评价Infrared attenuated total reflection and 2D fluorescence spectroscopy for the discrimination of differently aggregated monoclonal antibodies.

期刊：The Analyst发表年份：2019作者：Alina Handl; Ángela I López-Lorente; René Handrick; Boris Mizaikoff; Friedemann Hesse
阅读更多 →

药效评价A novel approach for protein identification from complex cell proteome using modified peptide mass fingerprinting algorithm.

期刊：Electrophoresis发表年份：2019作者：Sumit Kumar Singh; Garvit Goel; Anurag S Rathore
阅读更多 →